Cargando…
Correlation Study on the Expression of INSR, IRS-1, and PD-L1 in Nonsmall Cell Lung Cancer
OBJECTIVE: To study the expression and correlation of insulin receptor (INSR), insulin receptor substrate-1 (IRS-1), and programmed cell death ligand-1 (PD-L1) in nonsmall cell lung cancer (NSCLC). METHODS: 45 lung cancer tissues and 30 adjacent normal tissues of NSCLC patients diagnosed in the Seco...
Autores principales: | Ting, Ma, Miao, Yu-e, Yu, Feng-xiu, Luo, Guang-cai, Xu, Xin, Xiao, Li-xia, Zhang, Guo-qing, Chang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553505/ https://www.ncbi.nlm.nih.gov/pubmed/36245982 http://dx.doi.org/10.1155/2022/5233222 |
Ejemplares similares
-
INSR novel mutations identified in a Chinese family with severe INSR-related insulin resistance syndromes: A case report
por: Yu, Lu, et al.
Publicado: (2022) -
A meta-analysis of efficacy and safety of antibodies targeting PD-1/PD-L1 in treatment of advanced nonsmall cell lung cancer
por: Wang, Cuihua, et al.
Publicado: (2016) -
Molecular Mechanism of Expression Changes of Immunological Indexes of PD-1/sPD-L1 after Radiotherapy in Nonsmall Cell Lung Cancer
por: Qu, Yanli, et al.
Publicado: (2021) -
The correlation of serum sPD-1 and sPD-L1 levels with clinical, pathological characteristics and lymph node metastasis in nonsmall cell lung cancer patients
por: ANCIN, Burcu, et al.
Publicado: (2022) -
Anti-PD-1/PD-L1 antibody therapy for pretreated advanced nonsmall-cell lung cancer: A meta-analysis of randomized clinical trials
por: Zhou, Guo-Wu, et al.
Publicado: (2016)